Ethylene Glycol

Ethylene Glycol

SCHEMBL6444329

C=C([Si](C)(C)C)[Si](C)(C)C.OCCO

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1617647 0.84
Ammonia Solution, Strong SCHEMBL10938310 0.81
Ethylene Glycol SCHEMBL15227546 0.71 TSHR (0.56) TSHR
Ethylene Glycol SCHEMBL3427076 0.68 TSHR (0.50) TSHR
Ethylene Glycol SCHEMBL3863316 0.68 TSHR (0.50) TSHR
Ethylene Glycol SCHEMBL27399593 0.68 TSHR (0.50) TSHR
Ethylene Glycol SCHEMBL15227459 0.68 TSHR (0.50) TSHR
Ethylene Glycol SCHEMBL42568 0.68
Ethylene Glycol SCHEMBL3493119 0.68 TSHR (0.50) TSHR
Ethylene Glycol SCHEMBL15013924 0.68 TSHR (0.50) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190352262-A1 New Pleuromutilin Antibiotic Compounds, Compositions and Methods of Use and Synthesis UNIV YALE (US) 2019-11-21 US disclosed
WO-2018144717-A1 NEW PLEUROMUTILIN ANTIBIOTIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE AND SYNTHESIS YALE UNIVERSITY (US) 2018-08-09 WO disclosed
US-9828338-B2 Carbamate derivatives of lactam based N-acylethanolamine acid amidase (NAAA) inhibitors THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-11-28 US disclosed
US-20160068482-A1 CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2016-03-10 US disclosed
US-6867305-B2 Synthesis of epothilones, intermediates thereto and analogues thereof SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2005-03-15 US disclosed
US-20020058817-A1 Synthesis of epothilones, intermediates thereto and analogues thereof NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2002-05-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160068482-A1 CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS NAAA, FAAH, FAAH2 TSHR 4069/4885
US-20020058817-A1 Synthesis of epothilones, intermediates thereto and analogues thereof DHPS, PPOX, THPO TSHR 2965/4885
US-20190352262-A1 New Pleuromutilin Antibiotic Compounds, Compositions and Methods of Use and Synthesis PLEC, MLN, MRPL21 TSHR 2760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.